Evidence map›Paper›PMID 21501359›Full record

ArticleCellular microbiology2011

Mammalian antimicrobial peptide influences control of cutaneous Leishmania infection.

Manjusha M Kulkarni, Joseph Barbi, W Robert McMaster, Richard L Gallo, Abhay R Satoskar, Bradford S McGwire

Open access · bronzeAbstract read
In one paragraph

Article in Cellular microbiology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
5.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 51 citations in OpenAlex.

  1. Endogenous cathelicidin protects againstInfection and immunity · 2026
    Article
  2. Cathelicidins Limit IntracellularPathogens (Basel, Switzerland) · 2025
    Article
  3. Molecular interaction assaysThe journal of venomous animals and toxins including tropical diseases · 2025
    Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Cathelicidin Contributes to the Restriction ofFrontiers in immunology · 2019
    Article
  10. Emerging therapeutic targets for treatment of leishmaniasis.Expert opinion on therapeutic targets · 2018
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 3 countries.

Manjusha M KulkarniCenter for Microbial Interface Biology, The Ohio State University Medical Center, Columbus, OH, USA.
Joseph Barbi
W Robert McMaster
Richard L Gallo
Abhay R Satoskar
Bradford S McGwire
Ecologie Microbienne Lyon · FRInterface (United States) · USUniversity of British Columbia · CA

Funding

Cathelicidins in Skin ImmunityR01AI052453 · NIAID · VETERANS MEDICAL RESEARCH FDN/SAN DIEGO · PI GALLO, RICHARD L, NIZET, VICTOR · 2002 to 2017
$5.3M
Cathelicidin in Skin ImmunityR37AI052453 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Richard L Gallo, Victor Nizet · 2019 to 2026
$4.6M
NIAID NIH HHS R01 AI052453NIAID NIH HHS R37 AI052453
6 · The paper itself

Abstract

Cathelicidin-type antimicrobial peptides (CAMP) are important mediators of innate immunity against microbial pathogens acting through direct interaction with and disruption of microbial membranes and indirectly through modulation of host cell migration and activation. Using a mouse knock-out model in CAMP we studied the role of this host peptide in control of dissemination of cutaneous infection by the parasitic protozoan Leishmania. The presence of pronounced host inflammatory infiltration in lesions and lymph nodes of infected animals was CAMP-dependent. Lack of CAMP expression was associated with higher levels of IL-10 receptor expression in bone marrow, splenic and lymph node macrophages as well as higher anti-inflammatory IL-10 production by bone marrow macrophages and spleen cells but reduced production of the pro-inflammatory cytokines IL-12 and IFN-γ by lymph nodes. Unlike wild-type mice, local lesions were exacerbated and parasites were found largely disseminated in CAMP knockouts. Infection of CAMP knockouts with parasite mutants lacking the surface metalloprotease virulence determinant resulted in more robust disseminated infection than in control animals suggesting that CAMP activity is negatively regulated by parasite surface proteolytic activity. This correlated with the ability of the protease to degrade CAMP in vitro and co-localization of CAMP with parasites within macrophages. Our results highlight the interplay of antimicrobial peptides and Leishmania that influence the host immune response and the outcome of infection.

Indexed as

AnimalsAntimicrobial Cationic PeptidesCathelicidinsCytokinesInflammationLeishmaniaLeishmaniasis, CutaneousLymph NodesMacrophagesMiceMice, Inbred BALB CMice, KnockoutModels, BiologicalSpleenAntimicrobial Cationic PeptidesCathelicidinsCytokines

Identifiers

PMID21501359
PMCPMC3121678
OpenAlexW1857156467

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.